Literature DB >> 17986363

Localization of alpha 2 receptors in ocular tissues.

Elizabeth Woldemussie1, Mercy Wijono, David Pow.   

Abstract

Alpha 2 adrenergic agonists are used for controlling intraocular pressure (IOP) in the treatment of glaucoma. They have also been shown to be neuroprotective to retinal cells in a variety of injury models. Despite this significance, the localization of the three known alpha 2 adrenergic receptors has not been unequivocally established. The aim of this study was to determine the location of the three alpha 2 adrenergic receptors in ocular tissues using immunohistochemical techniques. New antibodies were generated and their specificity was determined using Western blotting and preadsorption. In the anterior segment of the eye alpha 2A immunoreactivity was located in the nonpigmented ciliary epithelium, corneal, and conjunctival epithelia. Alpha 2B staining was not apparent in these tissues. Alpha 2C immunostaining was present in the membrane of pigmented ciliary epithelium and corneal and conjunctival epithelial cells. In the rat retina, all three receptor subtypes were present but were differentially localized. Alpha 2A was present in the somata of ganglion cell layer and inner nuclear layer somas, alpha 2B was located in the dendrites and axons of most of the neurons as well as glia, while alpha 2C was present in the somata and inner segment of the photoreceptors. In human and monkey retinas, similar pattern of labeling for alpha 2A and 2B receptors were observed, while alpha 2B was additionally present in the membranes of many cell somata in addition to dendrites and axons. Alpha 2C labeling was much weaker but exhibited similar pattern to that observed in the rat. These data provide additional information on the location of the alpha 2 receptors in the anterior portion of the eye and present new information on their specific location in the retina. This offers insights into possible targets for adrenergic agonists in a therapeutic context.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986363     DOI: 10.1017/S0952523807070605

Source DB:  PubMed          Journal:  Vis Neurosci        ISSN: 0952-5238            Impact factor:   3.241


  20 in total

1.  Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.

Authors:  Grace C Shih; David J Calkins
Journal:  Expert Rev Ophthalmol       Date:  2012-04

Review 2.  Complement pathway biomarkers and age-related macular degeneration.

Authors:  M Gemenetzi; A J Lotery
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

3.  Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability.

Authors:  Yunpeng Du; Megan Cramer; Chieh Allen Lee; Jie Tang; Arivalagan Muthusamy; David A Antonetti; Hui Jin; Krzysztof Palczewski; Timothy S Kern
Journal:  FASEB J       Date:  2015-02-09       Impact factor: 5.191

4.  Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.

Authors:  Yu Chen; Grazyna Palczewska; Debarshi Mustafi; Marcin Golczak; Zhiqian Dong; Osamu Sawada; Tadao Maeda; Akiko Maeda; Krzysztof Palczewski
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

5.  Topical mydriatics affect light-evoked retinal responses in anesthetized mice.

Authors:  Deb Kumar Mojumder; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

6.  Corneal Anesthesia With Site 1 Sodium Channel Blockers and Dexmedetomidine.

Authors:  James Brian McAlvin; Changyou Zhan; Jenny C Dohlman; Paraskevi E Kolovou; Borja Salvador-Culla; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

7.  Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine.

Authors:  Anna Krzyczmonik; Thomas Keller; Francisco R López-Picón; Sarita Forsback; Anna K Kirjavainen; Jatta S Takkinen; Aleksandra Wasilewska; Mika Scheinin; Merja Haaparanta-Solin; Franciszek Sączewski; Olof Solin
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

8.  Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation.

Authors:  Tong Li; Shiqi Yang; Xiangjun She; Quan Yan; Pengfei Zhang; Hong Zhu; Fenghua Wang; Xueting Luo; Xiaodong Sun
Journal:  Br J Pharmacol       Date:  2019-01-30       Impact factor: 8.739

9.  Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.

Authors:  Kelvin Yoon Chiang Lee; Mao Nakayama; Makoto Aihara; Yi-Ning Chen; Makoto Araie
Journal:  Mol Vis       Date:  2010-02-17       Impact factor: 2.367

10.  Safety threshold of intravitreal clonidine in rabbit's eyes.

Authors:  Homayoun Nikkhah; Kiumars Heidari Garfami; Mozhgan Rezaei Kanavi; Ebrahim Mohammad Nashtaei; Saeed Karimi; Masoud Soheilian
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.